70515-700 : Rilutek 50 mg Oral Tablet


NDC: 70515-700
Labeler: Covis Pharma
Product Type: Human Prescription Drug
Drug Name:  Rilutek
Dosage Form: Oral Tablet
Application #: NDA020599
Rev. Date: 


Appearance:


Markings: RPR;202
Shapes:  Oval
Colors:  White
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

RPR 202: (0075-7700) Rilutek 50 mg Oral Tablet by Covis Pharma
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 70515-700-60: 1 BOTTLE IN 1 CARTON (70515‑700‑60) > 60 TABLET IN 1 BOTTLE

Active Ingredients:

  • Riluzole

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Calcium Phosphate, Dibasic, Anhydrous
  • Cellulose, Microcrystalline
  • Silicon Dioxide
  • Magnesium Stearate
  • Croscarmellose Sodium
  • Hypromelloses
  • Polyethylene Glycol 6000
  • Titanium Dioxide

Pharmaceutical Classes:

  • Benzothiazole [EPC]
  • Benzothiazoles [CS]

Related Products:

Based on records with the same trade name.
  • 0075-7700 Rilutek 50 mg Oral Tablet by Sanofi-aventis U.S. LLC
  • 0179-0143 Rilutek 50 mg/1 Oral Tablet by Kaiser Foundation Hospitals
  • 24987-700 Rilutek 50 mg Oral Tablet by Covis Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70515-700 QR Code

< Prev: 70515-630Next: 70515-701 >

Related Discussions:

riluzole for depression
anyone with experience using riluzole for treatment resistant depression ## Hello, Pance! How are you? I've not take... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.